Stock Track | METIS TECHBIO-P Plummets 5.5% Intraday Amid Post-IPO Profit-Taking and Cooling Market Enthusiasm

Stock Track05-28

METIS TECHBIO-P's stock plummeted 5.50% during intraday trading on Thursday, extending a sustained retreat since its market debut earlier this month.

The decline reflects ongoing profit-taking pressure and rapidly cooling post-IPO market enthusiasm. Despite recently announcing a strategic alliance with healthcare investment firm Deerfield Management to advance AI-driven protein therapeutics, the stock has faced selling pressure as some international placement shares were not subject to lock-up restrictions.

As the world's first AI-driven drug delivery company to list on the Hong Kong Stock Exchange, METIS TECHBIO-P remains in early-stage commercialization with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue. The market's initial exuberance following its 173% surge from the IPO price on debut has continued to fade, sustaining downward pressure on the share price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128992312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 11:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128992312","market":"hk","top_or_hot":-1,"title":"Stock Track | METIS TECHBIO-P Plummets 5.5% Intraday Amid Post-IPO Profit-Taking and Cooling Market Enthusiasm","media":"Stock Track","content":"<p>METIS TECHBIO-P's stock plummeted 5.50% during intraday trading on Thursday, extending a sustained retreat since its market debut earlier this month.</p><p>The decline reflects ongoing profit-taking pressure and rapidly cooling post-IPO market enthusiasm. Despite recently announcing a strategic alliance with healthcare investment firm Deerfield Management to advance AI-driven protein therapeutics, the stock has faced selling pressure as some international placement shares were not subject to lock-up restrictions.</p><p>As the world's first AI-driven drug delivery company to list on the Hong Kong Stock Exchange, METIS TECHBIO-P remains in early-stage commercialization with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue. The market's initial exuberance following its 173% surge from the IPO price on debut has continued to fade, sustaining downward pressure on the share price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | METIS TECHBIO-P Plummets 5.5% Intraday Amid Post-IPO Profit-Taking and Cooling Market Enthusiasm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | METIS TECHBIO-P Plummets 5.5% Intraday Amid Post-IPO Profit-Taking and Cooling Market Enthusiasm\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-28 11:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>METIS TECHBIO-P's stock plummeted 5.50% during intraday trading on Thursday, extending a sustained retreat since its market debut earlier this month.</p><p>The decline reflects ongoing profit-taking pressure and rapidly cooling post-IPO market enthusiasm. Despite recently announcing a strategic alliance with healthcare investment firm Deerfield Management to advance AI-driven protein therapeutics, the stock has faced selling pressure as some international placement shares were not subject to lock-up restrictions.</p><p>As the world's first AI-driven drug delivery company to list on the Hong Kong Stock Exchange, METIS TECHBIO-P remains in early-stage commercialization with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue. The market's initial exuberance following its 173% surge from the IPO price on debut has continued to fade, sustaining downward pressure on the share price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07666","symbol_name":"剂泰科技-P","start_time":0,"source_url":"","article_id":"1128992312","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128992312","pubTimestamp":1779940011,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"METIS TECHBIO-P's stock plummeted 5.50% during intraday trading on Thursday, extending a sustained retreat since its market debut earlier this month.The decline reflects ongoing profit-taking...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07666":"剂泰科技-P"},"translate_title":"个股追踪|METIS TECHBIO-P盘中暴跌5.5%，IPO后获利了结，市场热情降温","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07666":1},"content_text":"METIS TECHBIO-P's stock plummeted 5.50% during intraday trading on Thursday, extending a sustained retreat since its market debut earlier this month.The decline reflects ongoing profit-taking pressure and rapidly cooling post-IPO market enthusiasm. Despite recently announcing a strategic alliance with healthcare investment firm Deerfield Management to advance AI-driven protein therapeutics, the stock has faced selling pressure as some international placement shares were not subject to lock-up restrictions.As the world's first AI-driven drug delivery company to list on the Hong Kong Stock Exchange, METIS TECHBIO-P remains in early-stage commercialization with approximately RMB 1.5 billion in accumulated losses over the past three years and volatile revenue. The market's initial exuberance following its 173% surge from the IPO price on debut has continued to fade, sustaining downward pressure on the share price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128992312","isCrawlerRequest":true}